Editorial policy

GLP-1 medications are a health topic where accuracy matters and misinformation causes harm. These are the standards every guide and blog post on GLPMate is held to.

We never give dosing or medical advice

This is the line we do not cross. GLPMate is a tracking and education tool, not a clinician. Nothing we publish tells you what dose to take, when to change it, or what to do about a symptom. Those decisions belong with your prescriber and pharmacist, who know your history. Our content explains how these medicines are understood and what is worth tracking — and it points you back to your care team wherever a real decision is involved.

What we cite, and what we won't claim

Every clinical statement is sourced to primary references, in this order of preference:

• FDA prescribing information (the drug labels) for dosing schedules, half-lives, titration intervals, missed-dose rules and documented adverse-event rates.
• Peer-reviewed clinical trials — the STEP (semaglutide) and SURMOUNT (tirzepatide) programs in The New England Journal of Medicine, PIONEER for oral semaglutide, and comparable registration studies.
• Guidance from regulators and professional bodies where a labeled answer doesn't exist.

We do not make outcome or weight-loss promises, and we never attribute a clinical result to using our app. Where we mention trial findings, we frame them as published data from a specific study population — not as a prediction for you. Every article lists its sources, and statistics are attributed inline to the source they came from.

How often we refresh

Health content goes stale. We aim to re-check each guide and post against the current FDA labels and literature at least every 90 days, and we update pages sooner when a label changes or new evidence appears. Blog posts, guides and medication pages show a “Sources checked” date next to their sources, so you can see when that last happened.

Who writes our content

Our articles are bylined “the GLPMate team”: they are researched, written and edited by the people who build the app. We use AI writing tools to help draft and structure content; a member of our team then edits every piece and checks each clinical statement against the cited sources before it is published. We do not currently have a named clinical reviewer. If one joins, their name, credentials and review dates will appear on the articles they review.

Translations

English is our source language. Most other language versions are translated with AI and checked automatically for missing text, numbers and units. Translations of health content that have not yet had a human review are flagged internally as pending review. If a translation and the English page disagree, the English page is the reference — please tell us so we can fix it.

Corrections

If you spot something inaccurate or out of date, tell us at support.eleutheromania@gmail.com. We correct errors promptly and update the page's “Last updated” date when we do.

This site is educational and is not medical advice, diagnosis or treatment. Always consult a qualified healthcare professional about your medication and your health.